Search - tctmd.com

Displaying 241 - 260 of 1332

Sort: Relevancy | Date

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

News Daily News

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

February 18, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

Transcatheter Aortic Valve Replacement (TAVR) in a Bicuspid Aortic Valve Stenosis

Presentation BIT 2020

Transcatheter Aortic Valve Replacement (TAVR) in a Bicuspid Aortic Valve Stenosis

Presenter: Rabin Chakraborty

February 02, 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

News Conference News STS 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Yael L. Maxwell

January 30, 2020

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

News Daily News

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

January 29, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

The Future of Transcatheter Heart Valve Therapy: Where are we Going?

Presentation Live Valves 2019

The Future of Transcatheter Heart Valve Therapy: Where are we Going?

Presenter: Martin B. Leon

December 10, 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

November 27, 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.